Novabridge BiosciencesNBP
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 29 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings, up 1 from Q4 2024. 5 opened new positions and 3 sold out. The largest holders were HHLR Advisors, LTD. ($4.9M), SG Americas Securities, LLC ($677K) and Stonepine Capital Management, LLC ($398K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q1 2025)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $493K |
| Exits | 3 | $121K |
All 13F filers, Q4 2024 → Q1 2025: 1,177,157 shares bought and 3,875,506 shares sold, net −2,698,349 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| HHLR Advisors, LTD. | 0.14% | No change | 5,980,568 | $4.9M |
| SG Americas Securities, LLC | 0.00% | Add +72.8% | 822,041 | $677K |
| Stonepine Capital Management, LLC | 0.39% | New | 483,647 | $398K |
| Two Sigma Advisers, LP | 0.00% | Reduce -15.7% | 363,200 | $299K |
| UBS Group AG | 0.00% | Add +209.1% | 318,546 | $262K |
| Two Sigma Investments, LP | 0.00% | Reduce -36.3% | 210,366 | $173K |
| Aberdeen Group plc | 0.00% | No change | 162,580 | $134K |
| BNP Paribas Financial Markets | 0.00% | Add +10.7% | 120,909 | $100K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $62K |
| Renaissance Technologies | 0.00% | No change | 63,800 | $53K |
| Ground Swell Capital, LLC | 0.12% | New | 63,730 | $53K |
| Millennium Management | 0.00% | Reduce -37.1% | 61,478 | $51K |
| Dimensional Fund Advisors LP | 0.00% | No change | 58,358 | $48K |
| HBK Sorce Advisory LLC | 0.00% | New | 46,060 | $38K |
| Morgan Stanley | 0.00% | Reduce -99.0% | 34,817 | $29K |
| Barclays PLC | 0.00% | No change | 30,370 | $25K |
| Mariner, LLC | 0.00% | No change | 28,760 | $24K |
| Geode Capital Management, LLC | 0.00% | No change | 22,037 | $18K |
| HRT Financial LP | 0.00% | Add +22.2% | 15,991 | $13K |
| Goldman Sachs Group Inc. | 0.00% | No change | 10,685 | $9K |
| Freestone Capital Holdings, LLC | 0.00% | No change | 10,000 | $8K |
| JPMorgan Chase & Co. | 0.00% | New | 5,000 | $4K |
| Simplex Trading, LLC | 0.00% | Add +296.7% | 3,229 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 905 | $746 |
| Bank of America Corp. | 0.00% | No change | 566 | $466 |
| Rhumbline Advisers | 0.00% | Reduce -73.6% | 361 | $297 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 200 | $165 |
| Citigroup Inc. | 0.00% | No change | 50 | $41 |
| Osaic Holdings, Inc. | 0.00% | New | 30 | $24 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.